rs61733388
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_007214.5(SEC63):c.2027C>T(p.Thr676Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0216 in 1,577,850 control chromosomes in the GnomAD database, including 454 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_007214.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEC63 | NM_007214.5 | c.2027C>T | p.Thr676Ile | missense_variant | 19/21 | ENST00000369002.9 | NP_009145.1 | |
SEC63 | XM_047418130.1 | c.1859C>T | p.Thr620Ile | missense_variant | 19/21 | XP_047274086.1 | ||
SEC63 | XM_047418131.1 | c.1607C>T | p.Thr536Ile | missense_variant | 18/20 | XP_047274087.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEC63 | ENST00000369002.9 | c.2027C>T | p.Thr676Ile | missense_variant | 19/21 | 1 | NM_007214.5 | ENSP00000357998 | P1 | |
SEC63 | ENST00000459782.1 | n.830C>T | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
SEC63 | ENST00000473746.1 | n.674C>T | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0172 AC: 2529AN: 147240Hom.: 27 Cov.: 30
GnomAD3 exomes AF: 0.0174 AC: 4368AN: 250980Hom.: 47 AF XY: 0.0177 AC XY: 2406AN XY: 135666
GnomAD4 exome AF: 0.0220 AC: 31515AN: 1430536Hom.: 427 Cov.: 28 AF XY: 0.0216 AC XY: 15422AN XY: 713366
GnomAD4 genome AF: 0.0172 AC: 2527AN: 147314Hom.: 27 Cov.: 30 AF XY: 0.0161 AC XY: 1146AN XY: 71360
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 16, 2020 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Polycystic liver disease 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at